TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
  • December 20, 2019

SILVER SPRING, MD—The FDA has launched an internet-based platform called CURE ID that allows professionals in the clinical community to use the website, a smartphone, or other mobile device to report their experiences treating infectious diseases using existing FDA-approved drugs in novel ways. The platform captures clinical outcomes when drugs are used for new indications, populations, doses, and/or combinations, facilitating crowdsourcing of medical information from healthcare providers to guide potentially life-saving interventions and the development of new drugs for neglected diseases. The platform is a result of a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH).